Friday, April 11, 2008

Vytorin: Just how much does Schering-Plough hate Merck?

This much, page 52.




Soren Bo Christiansen is the General Manager Bone, Respiratory, Immunology and
Endocrine Franchise, Merck & Co., Inc. Enrico Veltri is the Schering-Plough group vice president of global clinical development and a leader of the Vytorin joint venture with Merck

No comments: